Showing results (1631-1640 of 4,601) with videos related to

Sort By:
Pageof 461
Chemmedchem|May 29, 2012
Selectively guanidinylated aminoglycosides as antibioticsRichard J Fair, Mary E Hensler, Wdee Thienphrapa, et al.
Chemmedchem|May 29, 2012
Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moietyKai Lv, Yexin Sun, Lanyin Sun, et al.
Chemmedchem|November 15, 2011
High-affinity, selective σ ligands of the 1,2,3,4-tetrahydro-1,4'-silaspiro[naphthalene-1,4'-piperidine] type: syntheses, structures, and pharmacological propertiesReinhold Tacke, Rüdiger Bertermann, Christian Burschka, et al.
Chemmedchem|August 7, 2018
Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor ActivityKenneth K Laali, William J Greves, Angela T Zwarycz, et al.
Chemmedchem|July 7, 2018
The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein SystemJan-Patrick Fischer, Sylvia Els-Heindl, Ria Schönauer, et al.
Chemmedchem|September 11, 2018
Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside AnaloguesMagdalena Slusarczyk, Valentina Ferrari, Michaela Serpi, et al.
Chemmedchem|August 14, 2018
Synthesis and Biological Evaluation of Reniochalistatins A-E and a Reniochalistatin E AnalogueRong Zhou, Yueguang Sun, Hangbin Li, et al.
Chemmedchem|January 26, 2022
Desorption Electrospray Ionization Mass Spectrometry Assay for Label-Free Characterization of SULT2B1b Enzyme KineticsSamadhi C Kulathunga, Nicolás M Morato, Qing Zhou, et al.
Chemmedchem|January 29, 2008
A 3D QSAR model of 17beta-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein dockingSampo Karkola, Annamaria Lilienkampf, Kristiina Wähälä
Chemmedchem|January 9, 2008
Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors-nanomolar-potency inhibitors of pancreatic cancer cell growthAlan P Kozikowski, Yufeng Chen, Arsen M Gaysin, et al.
Pageof 461